Clinicopathologic analysis of the impact of CD23 expression in plasma cell myeloma with t(11;14)(q13;q32)

Annals of Diagnostic Pathology

Volumn 15, Issue 6, 2011, Pages 385-388

  Buonaccorsi, J Noelle ^a   Kroft, Steven H ^a   Harrington, Alexandra M ^a   Vantuinen, Peter ^a   Olteanu, Horatiu ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Bone marrow biopsy; CD23; Immunohistochemistry; Plasma cell myeloma

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; CALCIUM; CD19 ANTIGEN; CD20 ANTIGEN; CD23 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CREATININE; HEMOGLOBIN; IMMUNOGLOBULIN G; LACTATE DEHYDROGENASE; STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE LESION; BONE MARROW BIOPSY; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME DELETION; CLINICAL ARTICLE; CORRELATIONAL STUDY; DIPLOIDY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; GOLGI STAIN; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPE; LABORATORY; LEUKOCYTE COUNT; MALE; MULTIPLE MYELOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BONE MARROW; CHROMOSOMES, HUMAN, PAIR 11; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PLATELET COUNT; RECEPTORS, IGE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 81155131189     PISSN: 10929134     EISSN: 15328198     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2011.04.004     Document Type: Article

References (16)

1. R.W. McKenna, R.A. Kyle, and W.M. Kuehl Plasma cell neoplasms S.H. Swerdlow, WHO Classification of Tumours of Hematopoietic and Neoplastic TIssues 2008 IARC Lyon 200 213
2. H. Avet-Loiseau, M. Attal, and P. Moreau Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome Blood 109 8 2007 3489 3495 (Pubitemid 46572539)
3. R. Fonseca, P.L. Bergsagel, and J. Drach International Myeloma Working Group molecular classification of multiple myeloma: spotlight review Leukemia 23 12 2009 2210 2221
4. M. Hundemer, U. Klein, and D. Hose Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14) Bone Marrow Transplant 40 11 2007 1033 1037 (Pubitemid 350142555)
5. G. Mateo, M. Castellanos, and A. Rasillo Genetic abnormalities and patterns of antigenic expression in multiple myeloma Clin Cancer Res 11 10 2005 3661 3667 (Pubitemid 40685582)
6. R.G. Hibbert, P. Teriete, and G.J. Grundy The structure of human CD23 and its interactions with IgE and CD21 J Exp Med 202 6 2005 751 760 (Pubitemid 41345964)
7. H. Olteanu, T.S. Fenske, and A.M. Harrington CD23 expression in follicular lymphoma: clinicopathologic correlations Am J Clin Pathol 135 1 2011 46 53
8. K. Kelemen, L.C. Peterson, and I. Helenowski CD23+ mantle cell lymphoma: a clinical pathologic entity associated with superior outcome compared with CD23-disease Am J Clin Pathol 130 2 2008 166 177
9. M. Walters, H. Olteanu, and P. Van Tuinen CD23 expression in plasma cell myeloma is specific for abnormalities of chromosome 11, and is associated with primary plasma cell leukaemia in this cytogenetic sub-group Br J Haematol 149 2 2010 292 293
10. N.A. Heerema, S.C. Raimondi, and J.R. Anderson Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia Genes Chromosomes Cancer 46 7 2007 684 693 (Pubitemid 46802336)
11. A.M. Harrington, P. Hari, and S.H. Kroft Utility of CD56 immunohistochemical studies in follow-up of plasma cell myeloma Am J Clin Pathol 132 1 2009 60 66
12. N.I. Pathan, P. Chu, and K. Hariharan Mediation of apoptosis by and antitumor activity of lumiliximab in chronic lymphocytic leukemia cells and CD23+ lymphoma cell lines Blood 111 3 2008 1594 1602 (Pubitemid 351213450)
13. H. Olteanu, A.M. Harrington, and P. Hari CD200 expression in plasma cell myeloma Br J Haematol 2011
14. E. Cannizzo, E. Bellio, and A.R. Sohani Multiparameter immunophenotyping by flow cytometry in multiple myeloma: The diagnostic utility of defining ranges of normal antigenic expression in comparison to histology Cytometry B Clin Cytom 78 4 2010 231 238
15. R. Dadmarz, and J.C. Cawley Heterogeneity of CLL: high CD23 antigen and alpha IFN receptor expression are features of favourable disease and of cell activation Br J Haematol 68 3 1988 279 282
16. J. Linderoth, M. Jerkeman, and E. Cavallin-Stahl Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study Clin Cancer Res 9 2 2003 722 728 (Pubitemid 36182606)